• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同基因型结核分枝杆菌耐药菌株分离患者的结核病化疗疗效]

[Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].

作者信息

Vasil'eva I A, Andreevskaia S N, Smirnova T G, Chernousova L I, Chukanov V I

出版信息

Probl Tuberk Bolezn Legk. 2004(8):25-8.

PMID:15478554
Abstract

Two hundred and twenty-four patients with pulmonary tuberculosis and bacterial isolation were examined to study the efficiency of chemotherapy in patients who isolated drug-resistant strains of Mycobacterium tuberculosis (MBT) of different genotypes. According to the pattern of susceptibility to antituberculous drugs (ATDs), the patients were divided into 3 groups: 1) those who were found to have ATD-susceptible MBT; 2) those who had multiresistant MBT susceptible to all ATDs, other than isoniazid and rifampicin; 3) those with multidrug resistance. MBT genotyping in accordance with the polymorphism of the length of restriction fragments IS6110 has indicated that the strains of the families W and AI were prevalent in all the groups. However, the strains of mycobacteria of the W family were most frequently (62%) detected among the patients with tuberculosis with slight drug resistance. Treatment was performed in accordance with the data of tests of MBT for their susceptibility to chemical agents. Comparison of the efficiency of therapy failed to reveal any relationship of the genotype of the causative agent within the groups of patients with tuberculosis with different resistance of Mycobacteria, including those with slight drug resistance. At the same time, the pattern of drug susceptibility of MBT largely determined the frequency and trends of bacterial isolation cessation.

摘要

对224例肺结核且有细菌分离结果的患者进行了检查,以研究化疗对分离出不同基因型结核分枝杆菌(MBT)耐药菌株患者的疗效。根据对抗结核药物(ATD)的敏感模式,将患者分为3组:1)那些被发现具有对ATD敏感的MBT的患者;2)那些具有对除异烟肼和利福平之外的所有ATD敏感的多重耐药MBT的患者;3)那些具有耐多药的患者。根据限制片段IS6110长度的多态性进行的MBT基因分型表明,W家族和AI家族的菌株在所有组中均占主导地位。然而,在耐药性轻微的肺结核患者中,W家族分枝杆菌菌株的检出频率最高(62%)。治疗是根据MBT对化学药物敏感性测试的数据进行的。对治疗效果的比较未能揭示在具有不同分枝杆菌耐药性(包括耐药性轻微的患者)的肺结核患者组中病原体基因型之间的任何关联。与此同时,MBT的药敏模式在很大程度上决定了细菌分离停止的频率和趋势。

相似文献

1
[Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].[不同基因型结核分枝杆菌耐药菌株分离患者的结核病化疗疗效]
Probl Tuberk Bolezn Legk. 2004(8):25-8.
2
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].[化疗与静脉输注溶解臭氧同时使用时分枝杆菌耐药性的变化]
Probl Tuberk Bolezn Legk. 2004(7):32-5.
3
[New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].[结核分枝杆菌药敏测定的新技术]
Probl Tuberk Bolezn Legk. 2004(6):40-2.
4
[Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].[多药耐药性肺结核的治疗效果]
Probl Tuberk. 2002(12):18-23.
5
[A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].[生物芯片检测在青少年活动性肺结核分枝杆菌利福平耐药性测定中的作用]
Probl Tuberk Bolezn Legk. 2004(8):28-30.
6
[The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].[疾病不同部位结核分枝杆菌的耐药率及模式]
Probl Tuberk Bolezn Legk. 2008(12):5-8.
7
[Artificial pneumoperitoneum in the complex treatment of pulmonary tuberculosis patients isolating drug-resistant mycobacterium tuberculosis].
Probl Tuberk Bolezn Legk. 2006(8):23-6.
8
[Genotyping mycobacteria, isolated from incarcerated tuberculosis patients].
Probl Tuberk. 2001(7):60-2.
9
[Drug resistant tuberculosis in children and adolescents].[儿童和青少年耐多药结核病]
Probl Tuberk. 2003(1):25-8.
10
[Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].新发破坏性肺结核患者中结核分枝杆菌的原发性耐药性
Probl Tuberk Bolezn Legk. 2009(4):37-9.